These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1371123)
1. Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine. Lillienau J; Schteingart CD; Hofmann AF J Clin Invest; 1992 Feb; 89(2):420-31. PubMed ID: 1371123 [TBL] [Abstract][Full Text] [Related]
2. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection. Longmire-Cook SJ; Lillienau J; Kim YS; Schteingart CD; Danzinger RG; Esch O; Hofmann AF Dig Dis Sci; 1992 Aug; 37(8):1217-27. PubMed ID: 1379904 [TBL] [Abstract][Full Text] [Related]
3. Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation. Schmassmann A; Angellotti MA; Ton-Nu HT; Schteingart CD; Marcus SN; Rossi SS; Hofmann AF Gastroenterology; 1990 Jan; 98(1):163-74. PubMed ID: 1688373 [TBL] [Abstract][Full Text] [Related]
4. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans. Schmassmann A; Fehr HF; Locher J; Lillienau J; Schteingart CD; Rossi SS; Hofmann AF Gastroenterology; 1993 Apr; 104(4):1171-81. PubMed ID: 7681796 [TBL] [Abstract][Full Text] [Related]
6. [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs. Frisch K; Jakobsen S; Sørensen M; Munk OL; Alstrup AK; Ott P; Hofmann AF; Keiding S J Nucl Med; 2012 May; 53(5):772-8. PubMed ID: 22454486 [TBL] [Abstract][Full Text] [Related]
7. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon. Kapral C; Wewalka F; Praxmarer V; Lenz K; Hofmann AF Z Gastroenterol; 2004 Jul; 42(7):583-9. PubMed ID: 15248106 [TBL] [Abstract][Full Text] [Related]
8. Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats. Heuman DM; Vlahcevic ZR; Pandak WM; Hylemon PB; Kim YS; Lillienau J; Hofmann AF Gastroenterology; 1992 Nov; 103(5):1641-8. PubMed ID: 1385253 [TBL] [Abstract][Full Text] [Related]
9. Cholylsarcosine for bile acid deficiency caused by ileal resection. Popović OS; Jojić N; Necić D Dig Dis Sci; 1999 Sep; 44(9):1931-2. PubMed ID: 10505737 [No Abstract] [Full Text] [Related]
10. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Heydorn S; Jeppesen PB; Mortensen PB Scand J Gastroenterol; 1999 Aug; 34(8):818-23. PubMed ID: 10499484 [TBL] [Abstract][Full Text] [Related]
12. [Cholysarkosin in treatment of bile acid deficiency syndrome]. Weinand I; Stein J Z Gastroenterol; 1999 Jul; 37(7):675-7. PubMed ID: 10458016 [No Abstract] [Full Text] [Related]
13. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome. Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242 [TBL] [Abstract][Full Text] [Related]
14. Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl- Frisch K; Kjærgaard K; Horsager J; Schacht AC; Munk OL Nucl Med Biol; 2019; 72-73():55-61. PubMed ID: 31330413 [TBL] [Abstract][Full Text] [Related]
15. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man. Hofmann AF; Molino G; Milanese M; Belforte G J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120 [TBL] [Abstract][Full Text] [Related]
16. Conjugated bile acid replacement therapy for short-bowel syndrome. Gruy-Kapral C; Little KH; Fordtran JS; Meziere TL; Hagey LR; Hofmann AF Gastroenterology; 1999 Jan; 116(1):15-21. PubMed ID: 9869597 [TBL] [Abstract][Full Text] [Related]
17. Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine. Michael S; Thöle M; Dillmann R; Fahr A; Drewe J; Fricker G Eur J Pharm Sci; 2000 Apr; 10(2):133-40. PubMed ID: 10727879 [TBL] [Abstract][Full Text] [Related]
18. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome. Fürst T; Bott C; Stein J; Dressman JB J Pharm Pharmacol; 2005 Jan; 57(1):53-60. PubMed ID: 15638993 [TBL] [Abstract][Full Text] [Related]
19. Functional assessment of hepatobiliary secretion by Ørntoft N; Frisch K; Ott P; Keiding S; Sørensen M Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1240-1244. PubMed ID: 29197661 [TBL] [Abstract][Full Text] [Related]
20. Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat. Holzinger F; Schteingart CD; Ton-Nu HT; Eming SA; Monte MJ; Hagey LR; Hofmann AF Hepatology; 1997 Nov; 26(5):1263-71. PubMed ID: 9362371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]